Abstract
New percutaneous technologies are rapidly emerging for the treatment of structural heart disease including mitral valve disease. Preliminary data suggest a potential clinical benefit of percutaneous treatment of mitral regurgitation by the MitraClip procedure in selected patients. Until final data are available from randomized, controlled, multicenter clinical trials, there is an urgent need for a consensus among all the operators involved in the treatment of patients with mitral regurgitation, including clinical cardiologists, heart failure specialists, surgeons, interventional cardiologists, and imaging experts. In the absence of evidence-based guidelines, the heart-team approach is the most reliable method of making proper decisions. This study is the result of multidisciplinary consensus activity, and has the aim of helping physicians in the difficult task of making decisions for the treatment of patients with mitral regurgitation. It is the result of a joint effort of the major Italian Cardiology and Cardiac Surgery Societies, working together to find a proper balance between the points of view of the clinical cardiologist, the interventional cardiologist, and the cardiac surgeon.
| Original language | English |
|---|---|
| Pages (from-to) | 173-188 |
| Number of pages | 16 |
| Journal | Journal of Cardiovascular Medicine |
| Volume | 15 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 2014 |
Fingerprint
Keywords
- MitraClip
- percutaneous mitral repair
- transcatheter
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
- Medicine(all)
Cite this
Transcatheter treatment of chronic mitral regurgitation with the MitraClip system : An Italian consensus statement. / Maisano, Francesco; Alamanni, Francesco; Alfieri, Ottavio; Bartorelli, Antonio; Bedogni, Francesco; Bovenzi, Francesco M.; Bruschi, Giuseppe; Colombo, Antonio; Cremonesi, Alberto; Denti, Paolo; Ettori, Federica; Klugmann, Silvio; La Canna, Giovanni; Martinelli, Luigi; Menicanti, Lorenzo; Metra, Marco; Oliva, Fabrizio; Padeletti, Luigi; Parolari, Alessandro; Santini, Francesco; Senni, Michele; Tamburino, Corrado; Ussia, Gian P.; Romeo, Francesco.
In: Journal of Cardiovascular Medicine, Vol. 15, No. 3, 2014, p. 173-188.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Transcatheter treatment of chronic mitral regurgitation with the MitraClip system
T2 - An Italian consensus statement
AU - Maisano, Francesco
AU - Alamanni, Francesco
AU - Alfieri, Ottavio
AU - Bartorelli, Antonio
AU - Bedogni, Francesco
AU - Bovenzi, Francesco M.
AU - Bruschi, Giuseppe
AU - Colombo, Antonio
AU - Cremonesi, Alberto
AU - Denti, Paolo
AU - Ettori, Federica
AU - Klugmann, Silvio
AU - La Canna, Giovanni
AU - Martinelli, Luigi
AU - Menicanti, Lorenzo
AU - Metra, Marco
AU - Oliva, Fabrizio
AU - Padeletti, Luigi
AU - Parolari, Alessandro
AU - Santini, Francesco
AU - Senni, Michele
AU - Tamburino, Corrado
AU - Ussia, Gian P.
AU - Romeo, Francesco
PY - 2014
Y1 - 2014
N2 - New percutaneous technologies are rapidly emerging for the treatment of structural heart disease including mitral valve disease. Preliminary data suggest a potential clinical benefit of percutaneous treatment of mitral regurgitation by the MitraClip procedure in selected patients. Until final data are available from randomized, controlled, multicenter clinical trials, there is an urgent need for a consensus among all the operators involved in the treatment of patients with mitral regurgitation, including clinical cardiologists, heart failure specialists, surgeons, interventional cardiologists, and imaging experts. In the absence of evidence-based guidelines, the heart-team approach is the most reliable method of making proper decisions. This study is the result of multidisciplinary consensus activity, and has the aim of helping physicians in the difficult task of making decisions for the treatment of patients with mitral regurgitation. It is the result of a joint effort of the major Italian Cardiology and Cardiac Surgery Societies, working together to find a proper balance between the points of view of the clinical cardiologist, the interventional cardiologist, and the cardiac surgeon.
AB - New percutaneous technologies are rapidly emerging for the treatment of structural heart disease including mitral valve disease. Preliminary data suggest a potential clinical benefit of percutaneous treatment of mitral regurgitation by the MitraClip procedure in selected patients. Until final data are available from randomized, controlled, multicenter clinical trials, there is an urgent need for a consensus among all the operators involved in the treatment of patients with mitral regurgitation, including clinical cardiologists, heart failure specialists, surgeons, interventional cardiologists, and imaging experts. In the absence of evidence-based guidelines, the heart-team approach is the most reliable method of making proper decisions. This study is the result of multidisciplinary consensus activity, and has the aim of helping physicians in the difficult task of making decisions for the treatment of patients with mitral regurgitation. It is the result of a joint effort of the major Italian Cardiology and Cardiac Surgery Societies, working together to find a proper balance between the points of view of the clinical cardiologist, the interventional cardiologist, and the cardiac surgeon.
KW - MitraClip
KW - percutaneous mitral repair
KW - transcatheter
UR - http://www.scopus.com/inward/record.url?scp=84897422558&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84897422558&partnerID=8YFLogxK
U2 - 10.2459/JCM.0000000000000004
DO - 10.2459/JCM.0000000000000004
M3 - Article
C2 - 24662461
AN - SCOPUS:84897422558
VL - 15
SP - 173
EP - 188
JO - Journal of Cardiovascular Medicine
JF - Journal of Cardiovascular Medicine
SN - 1558-2027
IS - 3
ER -